東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/08/12 | 2,000 | 2,029 | 1,997 | 2,026 | +19 | +0.9% | 72,800 |
2020/08/11 | 1,944 | 2,007 | 1,944 | 2,007 | +78 | +4% | 72,600 |
2020/08/07 | 1,936 | 1,943 | 1,914 | 1,929 | -5 | -0.3% | 57,900 |
2020/08/06 | 1,927 | 1,935 | 1,912 | 1,934 | -2 | -0.1% | 41,100 |
2020/08/05 | 1,953 | 1,975 | 1,928 | 1,936 | -31 | -1.6% | 56,800 |
2020/08/04 | 1,955 | 1,984 | 1,952 | 1,967 | +40 | +2.1% | 62,500 |
2020/08/03 | 1,902 | 1,935 | 1,897 | 1,927 | +38 | +2% | 37,500 |
2020/07/31 | 1,930 | 1,939 | 1,868 | 1,889 | -74 | -3.8% | 122,300 |
2020/07/30 | 1,960 | 1,976 | 1,941 | 1,963 | +2 | +0.1% | 127,200 |
2020/07/29 | 1,960 | 1,980 | 1,936 | 1,961 | -18 | -0.9% | 75,200 |
2020/07/28 | 1,987 | 1,999 | 1,969 | 1,979 | -8 | -0.4% | 82,500 |
2020/07/27 | 1,956 | 1,988 | 1,939 | 1,987 | -5 | -0.3% | 93,500 |
2020/07/22 | 1,993 | 2,013 | 1,979 | 1,992 | +2 | +0.1% | 67,800 |
2020/07/21 | 2,001 | 2,005 | 1,974 | 1,990 | -10 | -0.5% | 80,700 |
2020/07/20 | 1,980 | 2,005 | 1,958 | 2,000 | +20 | +1% | 54,900 |
2020/07/17 | 2,032 | 2,044 | 1,962 | 1,980 | -48 | -2.4% | 90,900 |
2020/07/16 | 2,040 | 2,057 | 2,010 | 2,028 | +18 | +0.9% | 147,600 |
2020/07/15 | 1,990 | 2,037 | 1,986 | 2,010 | +57 | +2.9% | 179,400 |
2020/07/14 | 1,919 | 1,967 | 1,908 | 1,953 | +42 | +2.2% | 117,100 |
2020/07/13 | 1,900 | 1,918 | 1,887 | 1,911 | +39 | +2.1% | 69,300 |
2020/07/10 | 1,878 | 1,892 | 1,865 | 1,872 | -8 | -0.4% | 73,600 |
2020/07/09 | 1,910 | 1,910 | 1,852 | 1,880 | -36 | -1.9% | 152,900 |
2020/07/08 | 1,916 | 1,951 | 1,915 | 1,916 | -5 | -0.3% | 116,900 |
2020/07/07 | 1,956 | 1,965 | 1,902 | 1,921 | -42 | -2.1% | 147,400 |
2020/07/06 | 1,961 | 1,989 | 1,955 | 1,963 | +34 | +1.8% | 74,800 |
2020/07/03 | 1,914 | 1,932 | 1,899 | 1,929 | +15 | +0.8% | 96,600 |
2020/07/02 | 1,921 | 1,932 | 1,905 | 1,914 | -5 | -0.3% | 127,600 |
2020/07/01 | 1,994 | 2,001 | 1,915 | 1,919 | -74 | -3.7% | 128,700 |
2020/06/30 | 2,015 | 2,024 | 1,993 | 1,993 | -9 | -0.4% | 74,200 |
2020/06/29 | 2,036 | 2,036 | 2,002 | 2,002 | -40 | -2% | 65,900 |
2020/06/26 | 2,040 | 2,059 | 2,021 | 2,042 | +16 | +0.8% | 78,800 |
2020/06/25 | 2,062 | 2,064 | 2,026 | 2,026 | -51 | -2.5% | 130,300 |
2020/06/24 | 2,083 | 2,095 | 2,068 | 2,077 | -7 | -0.3% | 72,500 |
2020/06/23 | 2,106 | 2,110 | 2,076 | 2,084 | -16 | -0.8% | 79,900 |
2020/06/22 | 2,071 | 2,108 | 2,058 | 2,100 | +19 | +0.9% | 71,800 |
2020/06/19 | 2,115 | 2,125 | 2,081 | 2,081 | -30 | -1.4% | 94,000 |
2020/06/18 | 2,125 | 2,127 | 2,094 | 2,111 | -22 | -1% | 71,900 |
2020/06/17 | 2,121 | 2,140 | 2,106 | 2,133 | -10 | -0.5% | 106,800 |
2020/06/16 | 2,066 | 2,147 | 2,049 | 2,143 | +93 | +4.5% | 138,900 |
2020/06/15 | 2,089 | 2,120 | 2,050 | 2,050 | -28 | -1.3% | 81,200 |
2020/06/12 | 2,099 | 2,099 | 2,062 | 2,078 | -64 | -3% | 131,600 |
2020/06/11 | 2,206 | 2,206 | 2,137 | 2,142 | -69 | -3.1% | 96,700 |
2020/06/10 | 2,230 | 2,232 | 2,200 | 2,211 | -15 | -0.7% | 65,100 |
2020/06/09 | 2,243 | 2,246 | 2,211 | 2,226 | -15 | -0.7% | 76,300 |
2020/06/08 | 2,255 | 2,255 | 2,224 | 2,241 | -28 | -1.2% | 85,600 |
2020/06/05 | 2,181 | 2,275 | 2,150 | 2,269 | +87 | +4% | 236,800 |
2020/06/04 | 2,220 | 2,259 | 2,135 | 2,182 | -46 | -2.1% | 425,900 |
2020/06/03 | 2,255 | 2,256 | 2,218 | 2,228 | -26 | -1.2% | 84,200 |
2020/06/02 | 2,261 | 2,261 | 2,232 | 2,254 | +23 | +1% | 88,800 |
2020/06/01 | 2,248 | 2,271 | 2,216 | 2,231 | -36 | -1.6% | 81,300 |
1051~
1100
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム